
Lurasidone - Schizophrenia and other psychoses
You are here : Home > Formulary Search > Lurasidone - Schizophrenia and other psychoses
Documentation
PAD Profile
Committee Recommendations (2)
The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the length of prescribing of anti-psychotics by the specialist team at Surrey & Borders Partnership NHS Foundation Trust as:
Mental Health specialist initiation and prescribing for at least 1 month and until the patient is stabilised on treatment prior to transfer of care to primary care.
Where a stabilised patient requires a simple, non-complex and non-urgent dose adjustment, this can be managed in primary care on recommendation by the specialist team.
The PCN recommends lurasidone as a treatment option in the management of schizophrenia once metabolic syndrome has been identified. Lurasidone will be initiated by a specialist from Surrey & Borders Partnership NHS Foundation Trust, in line with the lurasidone prescribing pathway (see Documentation). Transfer of prescribing responsibility (to primary care) may be considered following 3 months initial treatment by the specialist.
Other Indications
Below are listed other indications that Lurasidone is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Schizophrenia and other psychoses.